Brunei Darussalam vs Kazakhstan: Previously treated cases tested for RR-/MDR-TB
Brunei Darussalam
100.0%
in 2024
Kazakhstan
100.0%
in 2024
Brunei Darussalam rank
1st
Kazakhstan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Brunei Darussalam
- Kazakhstan
How they compare
Brunei Darussalam currently reports 100.0% against 100.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 6 times across 17 shared years of data; in 2007 it was Kazakhstan ahead.
Brunei Darussalam ranks 1st and Kazakhstan ranks 1st of 180 countries.
Brunei Darussalam has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brunei Darussalam | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 56.5% | 50.0% | 6.5% | Brunei Darussalam |
| 2010s | 99.0% | 87.4% | 11.6% | Brunei Darussalam |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Brunei Darussalam or Kazakhstan?
- Brunei Darussalam, at 100.0% against 100.0% in Kazakhstan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Brunei Darussalam and Kazakhstan?
- 0.0%, with Brunei Darussalam ahead.
- How many years of comparable data are there for Brunei Darussalam and Kazakhstan?
- 17 years are reported by both, from 2007 to 2024.
- How do Brunei Darussalam and Kazakhstan rank globally for previously treated cases tested for rr-/mdr-tb?
- Brunei Darussalam ranks 1st and Kazakhstan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.